European Association of Urology
Guidelines
Education & Events
Join our events Join our events
On-demand education Learn at your own pace
Scholarships Enrich your capabilities
Exchange Programmes Urology beyond Europe
Education Educational Platforms Talent Incubator Programme Accreditation
Science & Publications
Publications Our publications
Research & Science Passionate about research?
About
Who we are Our mission and history
Our Board and Offices How we work
Join the EAU Find out about membership
Vacancies Contact
Guidelines

Paediatric Urology

Want to read the guideline in your own time? Download the PDF

Download full guideline

Looking for a quick overview? Check the pocket guidelines.

Download pocket guidelines
Full text guidelineSummary of ChangesPublications & AppendicesPanelRelated content
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
2022
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • No elements found. Consider changing the search query.
  • List is empty.

For the 2022 Paediatric Urology Guidelines, 3 chapters of the Guidelines have been updated through a structured assessment of the literature and these additional references and text updates have been incorporated. A new section on Eosinophilic cystitis and Nephrogenic adenoma has been added to the chapter on bladder tumours.

Key changes in the 2022 publication:

  • Section 3.11 - Monosymptomatic nocturnal enuresis – bedwetting: Both the literature and the text have been extensively updated;
  • Section 3.12 - Management of neurogenic bladder: Both the literature and the text have been updated;
  • Section 3.16 - Obstructive pathology of renal duplication: ureterocele and ectopic ureter: The literature has been updated resulting in minor amendments to the text;
  • Section 3.19 – Rare Conditions – A new section has been added to the section on bladder tumours on eosinophilic cystitis and nephrogenic adenoma.

New recommendations

3.19         Recommendations for rare conditions in children

3.19.2.9  Recommendations for papillary tumours of the bladder in children

Recommendations

LE

Strength rating

Have a high index of suspicion of eosinophilic cystitis (EC) in protracted urinary tract symptoms unresponsive to regular treatment.

4

Strong

 

Any possible allergens as the obvious first step in managing EC.

4

Strong

Eosinophilic cystitis can be managed medically with corticosteroids, antibiotics,

anticholinergics, and antihistamines, in addition to cyclosporine A.

4

Weak

 

Manage nephrogenic adenoma (NE) by resection either transuretherally or by open excision.

4

Strong

 

Regular endoscopic follow-up especially for augmented patients with NA is justified.

4

Weak


About EAU
  • Who we are
  • How we work
  • Become a member
Services
  • MyEAU
  • Congress registrations
  • Abstract submission
Media
  • EAU News
  • EAU Newsletter
  • EAU Press Releases
Contact
  • EAU Central Office
    PO Box 30016
    NL-6803 AA ARNHEM
    The Netherlands

  • Contact us
About EAU
Who we areHow we workBecome a member
Services
MyEAUCongress registrationsAbstract submission
Media
EAU NewsEAU NewsletterEAU Press Releases
Contact

EAU Central Office
PO Box 30016
NL-6803 AA ARNHEM
The Netherlands

Contact us
European Association of Urology
Privacy PolicyDisclaimer